2 completed, 2 terminated, 2 unknown, 1 withdrawn. 7 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 2, Terminated 2, Unknown 2, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Ovidrel: new trials by email Literature Review of Ovidrel trials Research Report on Ovidrel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole Progesterone Vaginal Gel 8%, Letrozole Oral Tablet, pelvic ultrasound - Polycystic Ovary Syndrome | Phase 2 / Phase 3 | Completed | Eastern Virginia Medical School | 52 | 2012-07-06 | 2018-02-26 |
| Safety Study of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1 NTx 265 - Traumatic Brain Injury | Phase 2 | Unknown | University of Calgary | 10 | 2010-11-01 | 2010-11-11 |
| To Describe the Effect of rhLH Supplementation in Women With Hyporesponse to rhFSH After Pituitary Downregulation Luveris - Infertility | Phase 2 | Unknown | Peking University Third Hospital | 150 | 2009-12-01 | 2009-12-10 |
| Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients human chorionic gonadotropin (hCG), then epoetin alfa (EPO), Saline Placebo - Stroke | Phase 2 | Terminated | Stem Cell Therapeutics Corp. | 96 | 2009-08-01 | 2011-11-29 |
| REGENESIS (US): A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients NTx™-265: rhCG, then rEPO, Saline Placebo - Stroke | Phase 2 | Withdrawn | Stem Cell Therapeutics Corp. | 30 | 2009-08-01 | 2011-09-05 |
| REGENESIS (CA): A Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients NTx™-265: rhCG, then rEPO, Saline placebo - Stroke | Phase 2 | Terminated | Stem Cell Therapeutics Corp. | 134 | 2008-03-01 | 2009-08-12 |
| Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART) AS900672-Enriched 50 microgram (mcg), AS900672-Enriched 100 mcg, AS900672-Enriched 150 mcg - Infertility | Phase 2 | Completed | Merck KGaA, Darmstadt, Germany | 520 | 2007-01-01 | 2014-02-13 |
Stroke (3) · Infertility (2) · Brain Injuries, Traumatic (1) · Polycystic Ovary Syndrome (1)
Stem Cell Therapeutics Corp. (3) · Eastern Virginia Medical School (1) · Merck KGaA, Darmstadt, Germany (1) · Peking University Third Hospital (1) · University of Calgary (1)
United States (4) · Canada (3) · India (2) · China (1)
Michael D Hill, MD (2) · Steven C Cramer, MD (2) · David A Zygun, MD, MSc (1) · Jie Qiao, MD, PhD (1) · Laurel A Stadtmauer, MD, PhD (1) · Steven C Cramer, MD, MMSc (1) · Zourab Bebia, MD (1)